Viewing Study NCT07061535

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 10:04 PM
Ignite Modification Date: 2026-06-18 @ 8:17 AM
Study NCT ID: NCT07061535
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-07-11
First Post: 2025-07-02
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Sintilimab Combined With Tafolecimab and Chemotherapy as First-Line Treatment for Extensive-Stage Small Cell Lung Cancer
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Extensive-stage Small Cell Lung Cancer (ES-SCLC) View
None Extensive Stage Lung Small Cell Cancer View
None Extensive-Stage Small-Cell Lung Cancer View
None Extensive Disease Small Cell Lung Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Tafolecimab View
None Sintilimab View
None immunotherapy View
None PCSK9 inhibitor View
None SCLC View